The Chemotherapy-Induced Neutropenia Treatment Market is a rapidly evolving sector that encompasses the development, manufacturing, and distribution of therapeutic interventions aimed at managing and preventing neutropenia, a common side effect of chemotherapy. Neutropenia is characterized by a significant decrease in neutrophil count, which weakens the immune system and increases the risk of infections in cancer patients undergoing […]
